(Corrects first bullet of outlook section to say Butterfly sees

2025 revenue at $91 million to $95 million, not $92 mln to $96

mln, after company clarifies)

Overview

* Butterfly Q2 revenue rises 9% yr/yr but missed analyst

expectations, per LSEG data

* Adjusted EPS beats analyst estimates, reflecting improved

operational efficiency

* Co achieved record gross margins of 64%, driven by higher

selling prices

Outlook

* Butterfly sees 2025 revenue at $91 mln to $95 mln

* Company expects 2025 adjusted EBITDA loss of $32 mln to

$37 mln

* Butterfly focuses on scaling core business and new revenue

streams

* Company plans to launch Compass AI software in Q3

Result Drivers

* RECORD GROSS MARGINS - Achieved 64% gross margins due to

higher

selling prices and improved software margins

* INTERNATIONAL REVENUE GROWTH - International revenue rose

19%

YoY, driven by price and volume increases from iQ3 launch

* AI CLINICAL APPLICATIONS - Three partners received FDA

clearance

for AI-powered applications, enhancing product offerings

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Miss $23.40 $23.70

Revenue mln mln (5

Analysts

)

Q2 Beat -$0.03 -$0.07

Adjusted (4

EPS Analysts

)

Q2 Gross $14.90

Profit mln

Analyst Coverage

* The current average analyst rating on the shares is "buy"

and

the breakdown of recommendations is 5 "strong buy" or "buy", no

"hold" and no "sell" or "strong sell"

* The average consensus recommendation for the advanced

medical

equipment & technology peer group is "buy"

* Wall Street's median 12-month price target for Butterfly

Network

Inc ( BFLY ) is $3.75, about 54.4% above its July 31 closing price of

$1.71

Press Release:

(This story was created using Reuters automation and AI based

on LSEG and company data. It was checked and edited by a Reuters

journalist prior to publication.)